

The global AI-based Embryo Grading Software market size is predicted to grow from US$ 37.3 million in 2025 to US$ 49.2 million in 2031; it is expected to grow at a CAGR of 4.7% from 2025 to 2031.
Embryo Grading Software is a specialized digital tool used in in vitro fertilization (IVF) to assess embryo quality. It automates embryo scoring, ranking, and selection based on morphological and developmental criteria, reducing subjectivity and improving implantation success rates. Many modern systems use AI, deep learning, and time-lapse imaging to enhance accuracy. AI is transforming Embryo Grading Software by enhancing accuracy, efficiency, and objectivity in selecting the best embryos for in vitro fertilization (IVF). Traditional embryo grading relies on manual evaluation by embryologists, but AI-powered systems use deep learning and computer vision to analyze embryos with greater precision.
United States market for AI-based Embryo Grading Software is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for AI-based Embryo Grading Software is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for AI-based Embryo Grading Software is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key AI-based Embryo Grading Software players cover Vitrolife, Genea BIOMEDX, MIM Fertility, Alife Health, Fairtility, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
The “AI-based Embryo Grading Software Industry Forecast” looks at past sales and reviews total world AI-based Embryo Grading Software sales in 2024, providing a comprehensive analysis by region and market sector of projected AI-based Embryo Grading Software sales for 2025 through 2031. With AI-based Embryo Grading Software sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world AI-based Embryo Grading Software industry.
This Insight Report provides a comprehensive analysis of the global AI-based Embryo Grading Software landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on AI-based Embryo Grading Software portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global AI-based Embryo Grading Software market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for AI-based Embryo Grading Software and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global AI-based Embryo Grading Software.
This report presents a comprehensive overview, market shares, and growth opportunities of AI-based Embryo Grading Software market by product type, application, key players and key regions and countries.
Segmentation by Type:
Web-based
Cloud-based
Segmentation by Application:
Hospital
Clinic
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Vitrolife
Genea BIOMEDX
MIM Fertility
Alife Health
Fairtility
ASTEC CO., Ltd
Care Fertility
Cycle Clarity
KritiKal Solutions
ImVitro
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global AI-based Embryo Grading Software Market Size (2020-2031)
2.1.2 AI-based Embryo Grading Software Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for AI-based Embryo Grading Software by Country/Region (2020, 2024 & 2031)
2.2 AI-based Embryo Grading Software Segment by Type
2.2.1 Web-based
2.2.2 Cloud-based
2.3 AI-based Embryo Grading Software Market Size by Type
2.3.1 AI-based Embryo Grading Software Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global AI-based Embryo Grading Software Market Size Market Share by Type (2020-2025)
2.4 AI-based Embryo Grading Software Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Other
2.5 AI-based Embryo Grading Software Market Size by Application
2.5.1 AI-based Embryo Grading Software Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global AI-based Embryo Grading Software Market Size Market Share by Application (2020-2025)
3 AI-based Embryo Grading Software Market Size by Player
3.1 AI-based Embryo Grading Software Market Size Market Share by Player
3.1.1 Global AI-based Embryo Grading Software Revenue by Player (2020-2025)
3.1.2 Global AI-based Embryo Grading Software Revenue Market Share by Player (2020-2025)
3.2 Global AI-based Embryo Grading Software Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 AI-based Embryo Grading Software by Region
4.1 AI-based Embryo Grading Software Market Size by Region (2020-2025)
4.2 Global AI-based Embryo Grading Software Annual Revenue by Country/Region (2020-2025)
4.3 Americas AI-based Embryo Grading Software Market Size Growth (2020-2025)
4.4 APAC AI-based Embryo Grading Software Market Size Growth (2020-2025)
4.5 Europe AI-based Embryo Grading Software Market Size Growth (2020-2025)
4.6 Middle East & Africa AI-based Embryo Grading Software Market Size Growth (2020-2025)
5 Americas
5.1 Americas AI-based Embryo Grading Software Market Size by Country (2020-2025)
5.2 Americas AI-based Embryo Grading Software Market Size by Type (2020-2025)
5.3 Americas AI-based Embryo Grading Software Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC AI-based Embryo Grading Software Market Size by Region (2020-2025)
6.2 APAC AI-based Embryo Grading Software Market Size by Type (2020-2025)
6.3 APAC AI-based Embryo Grading Software Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe AI-based Embryo Grading Software Market Size by Country (2020-2025)
7.2 Europe AI-based Embryo Grading Software Market Size by Type (2020-2025)
7.3 Europe AI-based Embryo Grading Software Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa AI-based Embryo Grading Software by Region (2020-2025)
8.2 Middle East & Africa AI-based Embryo Grading Software Market Size by Type (2020-2025)
8.3 Middle East & Africa AI-based Embryo Grading Software Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global AI-based Embryo Grading Software Market Forecast
10.1 Global AI-based Embryo Grading Software Forecast by Region (2026-2031)
10.1.1 Global AI-based Embryo Grading Software Forecast by Region (2026-2031)
10.1.2 Americas AI-based Embryo Grading Software Forecast
10.1.3 APAC AI-based Embryo Grading Software Forecast
10.1.4 Europe AI-based Embryo Grading Software Forecast
10.1.5 Middle East & Africa AI-based Embryo Grading Software Forecast
10.2 Americas AI-based Embryo Grading Software Forecast by Country (2026-2031)
10.2.1 United States Market AI-based Embryo Grading Software Forecast
10.2.2 Canada Market AI-based Embryo Grading Software Forecast
10.2.3 Mexico Market AI-based Embryo Grading Software Forecast
10.2.4 Brazil Market AI-based Embryo Grading Software Forecast
10.3 APAC AI-based Embryo Grading Software Forecast by Region (2026-2031)
10.3.1 China AI-based Embryo Grading Software Market Forecast
10.3.2 Japan Market AI-based Embryo Grading Software Forecast
10.3.3 Korea Market AI-based Embryo Grading Software Forecast
10.3.4 Southeast Asia Market AI-based Embryo Grading Software Forecast
10.3.5 India Market AI-based Embryo Grading Software Forecast
10.3.6 Australia Market AI-based Embryo Grading Software Forecast
10.4 Europe AI-based Embryo Grading Software Forecast by Country (2026-2031)
10.4.1 Germany Market AI-based Embryo Grading Software Forecast
10.4.2 France Market AI-based Embryo Grading Software Forecast
10.4.3 UK Market AI-based Embryo Grading Software Forecast
10.4.4 Italy Market AI-based Embryo Grading Software Forecast
10.4.5 Russia Market AI-based Embryo Grading Software Forecast
10.5 Middle East & Africa AI-based Embryo Grading Software Forecast by Region (2026-2031)
10.5.1 Egypt Market AI-based Embryo Grading Software Forecast
10.5.2 South Africa Market AI-based Embryo Grading Software Forecast
10.5.3 Israel Market AI-based Embryo Grading Software Forecast
10.5.4 Turkey Market AI-based Embryo Grading Software Forecast
10.6 Global AI-based Embryo Grading Software Forecast by Type (2026-2031)
10.7 Global AI-based Embryo Grading Software Forecast by Application (2026-2031)
10.7.1 GCC Countries Market AI-based Embryo Grading Software Forecast
11 Key Players Analysis
11.1 Vitrolife
11.1.1 Vitrolife Company Information
11.1.2 Vitrolife AI-based Embryo Grading Software Product Offered
11.1.3 Vitrolife AI-based Embryo Grading Software Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Vitrolife Main Business Overview
11.1.5 Vitrolife Latest Developments
11.2 Genea BIOMEDX
11.2.1 Genea BIOMEDX Company Information
11.2.2 Genea BIOMEDX AI-based Embryo Grading Software Product Offered
11.2.3 Genea BIOMEDX AI-based Embryo Grading Software Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Genea BIOMEDX Main Business Overview
11.2.5 Genea BIOMEDX Latest Developments
11.3 MIM Fertility
11.3.1 MIM Fertility Company Information
11.3.2 MIM Fertility AI-based Embryo Grading Software Product Offered
11.3.3 MIM Fertility AI-based Embryo Grading Software Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 MIM Fertility Main Business Overview
11.3.5 MIM Fertility Latest Developments
11.4 Alife Health
11.4.1 Alife Health Company Information
11.4.2 Alife Health AI-based Embryo Grading Software Product Offered
11.4.3 Alife Health AI-based Embryo Grading Software Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Alife Health Main Business Overview
11.4.5 Alife Health Latest Developments
11.5 Fairtility
11.5.1 Fairtility Company Information
11.5.2 Fairtility AI-based Embryo Grading Software Product Offered
11.5.3 Fairtility AI-based Embryo Grading Software Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Fairtility Main Business Overview
11.5.5 Fairtility Latest Developments
11.6 ASTEC CO., Ltd
11.6.1 ASTEC CO., Ltd Company Information
11.6.2 ASTEC CO., Ltd AI-based Embryo Grading Software Product Offered
11.6.3 ASTEC CO., Ltd AI-based Embryo Grading Software Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 ASTEC CO., Ltd Main Business Overview
11.6.5 ASTEC CO., Ltd Latest Developments
11.7 Care Fertility
11.7.1 Care Fertility Company Information
11.7.2 Care Fertility AI-based Embryo Grading Software Product Offered
11.7.3 Care Fertility AI-based Embryo Grading Software Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Care Fertility Main Business Overview
11.7.5 Care Fertility Latest Developments
11.8 Cycle Clarity
11.8.1 Cycle Clarity Company Information
11.8.2 Cycle Clarity AI-based Embryo Grading Software Product Offered
11.8.3 Cycle Clarity AI-based Embryo Grading Software Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Cycle Clarity Main Business Overview
11.8.5 Cycle Clarity Latest Developments
11.9 KritiKal Solutions
11.9.1 KritiKal Solutions Company Information
11.9.2 KritiKal Solutions AI-based Embryo Grading Software Product Offered
11.9.3 KritiKal Solutions AI-based Embryo Grading Software Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 KritiKal Solutions Main Business Overview
11.9.5 KritiKal Solutions Latest Developments
11.10 ImVitro
11.10.1 ImVitro Company Information
11.10.2 ImVitro AI-based Embryo Grading Software Product Offered
11.10.3 ImVitro AI-based Embryo Grading Software Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 ImVitro Main Business Overview
11.10.5 ImVitro Latest Developments
12 Research Findings and Conclusion
*If Applicable.